Literature DB >> 31169025

Compartmentalization of Redox-Regulated Signaling in the Pulmonary Circulation.

Stephen M Black1, Eva Nozik-Grayck2.   

Abstract

Oxidative stress is well recognized to contribute to the pathogenesis of diverse diseases, including the devastating disease of the lung's blood vessels, pulmonary arterial hypertension (PAH), however, antioxidant-based therapies have been overall disappointing. With the evolution of the field of redox biology, it is now becoming clear that redox reactions are highly selective and targeted, allowing for precise control of redox-regulated signaling in health and disease. This special Forum of the journal describes the current state of knowledge on the regulation of redox-regulated signaling during the development of pulmonary vascular disease, focusing on distinct compartmentalized mechanisms outside and within the cell, including regulation of extracellular and intracellular membrane receptors and channels; responses to changes in biomechanical forces; intracellular thiol redox control; regulation of the nuclear transcription factor, peroxisome proliferator-activated receptor-γ; and regulation of mitochondrial metabolism. Collectively, they exemplify the complex, precise, and localized signaling pathways that drive PAH pathogenesis. This group of authors suggests ways that our increased understanding of these events may pave the way to improved therapeutic approaches for the treatment of this lethal disease.

Entities:  

Keywords:  pulmonary hypertension; pulmonary vascular remodeling; pulmonary vasoconstriction; redox-regulated signaling

Year:  2019        PMID: 31169025      PMCID: PMC6751389          DOI: 10.1089/ars.2019.7809

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

2.  Redox Regulation of Ion Channels and Receptors in Pulmonary Hypertension.

Authors:  Laura Weise-Cross; Thomas C Resta; Nikki L Jernigan
Journal:  Antioxid Redox Signal       Date:  2019-01-25       Impact factor: 8.401

Review 3.  Mechanosignaling in the vasculature: emerging concepts in sensing, transduction and physiological responses.

Authors:  Shampa Chatterjee; Keigi Fujiwara; Néstor Gustavo Pérez; Masuko Ushio-Fukai; Aron B Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-10       Impact factor: 4.733

4.  Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.

Authors:  Hagir B Suliman; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

5.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

6.  Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.

Authors:  Stephen L Archer
Journal:  Circulation       Date:  2017-12-19       Impact factor: 29.690

Review 7.  Pulmonary Hypertension.

Authors:  Darlene Kim; M Patricia George
Journal:  Med Clin North Am       Date:  2019-05       Impact factor: 5.456

8.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

Review 9.  Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies.

Authors:  Thomas Hansen; Keyvan-Karimi Galougahi; David Celermajer; Nathalie Rasko; Owen Tang; Kristen J Bubb; Gemma Figtree
Journal:  Pharmacol Ther       Date:  2016-05-20       Impact factor: 12.310

  9 in total
  2 in total

Review 1.  Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.

Authors:  Dan Xu; Ya-Hui Hu; Xue Gou; Feng-Yang Li; Xi-Yu-Chen Yang; Yun-Man Li; Feng Chen
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

2.  Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.

Authors:  Di Chen; Hui-Fang Zhang; Tian-Yi Yuan; Shu-Chan Sun; Ran-Ran Wang; Shou-Bao Wang; Lian-Hua Fang; Yang Lyu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2022-02-21       Impact factor: 7.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.